TrialBMJ open2017

Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol.

Seyed Ali Jazayeri-Tehrani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.